Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tinavi Medical Technologies CoSHSE:688277 74 PB Ratio is 7.52 as of Jul. 21, 2026, which is 24% above its 10-year median of 6.08. GuruFocus rates SHSE:688277 with a GF Score™ of 74/100 and a GF Value™ of ¥19.55 (Fairly Valued). The stock has 5 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Tinavi Medical Technologies Co ranks worse than 87.53% on this metric.
The historical rank and industry rank for Tinavi Medical Technologies Co's PB Ratio or its related term are showing as below:
SHSE:688277'
s PB Ratio Range Over the Past 10 Years
Min: 2.34 Med: 6.08 Max: 46.12
Current: 7.52
During the past 13 years, Tinavi Medical Technologies Co's highest PB Ratio was 46.12. The lowest was 2.34. And the median was 6.08.
SHSE:688277's PB Ratio is ranked worse than 87.53% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 2.005
vs SHSE:688277: 7.52
During the past 12 months, Tinavi Medical Technologies Co's average Book Value Per Share Growth Rate was -12.20% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 1.50% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 3.00% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 12.00% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Tinavi Medical Technologies Co was 66.60% per year. The lowest was -7.20% per year. And the median was 19.25% per year.
Back to Basics: PB Ratio
Tinavi Medical Technologies Co (SHSE:688277) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Tinavi Medical Technologies Co PB Ratio Related Terms
Tinavi Medical Technologies Co PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688277 vs ISRG, BDX, MDLN: PB Ratio Comparison
For the Medical Instruments & Supplies subindustry, Tinavi Medical Technologies Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tinavi Medical Technologies Co PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tinavi Medical Technologies Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Tinavi Medical Technologies Co's PB Ratio falls into.
Tinavi Medical Technologies Co PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Tinavi Medical Technologies Co (SHSE:688277) has a PB Ratio of 7.52 as of Jul. 21, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Tinavi Medical Technologies Co and its competitors. This is 24% above median its historical median of 6.08. Over the past decade, Tinavi Medical Technologies Co's PB Ratio has ranged from 2.34 to 46.12. According to the industry distribution chart, Tinavi Medical Technologies Co ranks #688 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 87.5%.
Is Tinavi Medical Technologies Co's PB Ratio too high?
Tinavi Medical Technologies Co's current PB Ratio of 7.52 is 24% above median its 10-year median of 6.08. Over the past 10 years, this metric has ranged from a low of 2.34 to a high of 46.12. The Medical Devices & Instruments industry median PB Ratio is 2.01. Tinavi Medical Technologies Co's value of 7.52 is 275.1% above this industry median. Based on the distribution chart, Tinavi Medical Technologies Co ranks #688 out of 786 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Tinavi Medical Technologies Co has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Tinavi Medical Technologies Co's PB Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Tinavi Medical Technologies Co ranks #688 out of 786 companies for PB Ratio. This places Tinavi Medical Technologies Co in the lower half of its industry. The industry median PB Ratio is 2.01. Tinavi Medical Technologies Co's value of 7.52 is 275.1% above this benchmark. Historically, Tinavi Medical Technologies Co's own PB Ratio has ranged from 2.34 to 46.12 over the past decade. While the company's 10-year median is 6.08 vs. the industry median of 2.01, Tinavi Medical Technologies Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.01, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tinavi Medical Technologies Co's current PB Ratio of 7.52 is 275.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Tinavi Medical Technologies Co and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tinavi Medical Technologies Co's current PB Ratio is 7.52, which is 24% above median its own 10-year median of 6.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tinavi Medical Technologies Co stock overvalued right now?
Based on GuruFocus' analysis, Tinavi Medical Technologies Co (SHSE:688277) is currently considered Fairly Valued. The stock's GF Value™ is ¥19.55, compared to a current price of ¥19.09 — trading 2.4% below its estimated fair value. The current PB Ratio is 7.52, which is 24% above median its 10-year median of 6.08 and 275.1% above the Medical Devices & Instruments industry median of 2.01. Tinavi Medical Technologies Co's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Tinavi Medical Technologies Co (SHSE:688277), the current PB Ratio is 7.52 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tinavi Medical Technologies Co (SHSE:688277) Overvalued in 2026?
Based on GuruFocus' analysis, Tinavi Medical Technologies Co stock appears to be undervalued.
The current stock price of ¥19.09 is trading 2.4% below its estimated GF Value™ of ¥19.55.
GuruFocus considers Tinavi Medical Technologies Co to be Fairly Valued.
Key valuation signals for SHSE:688277:
PB Ratio: 7.52 (24% above median its 10-year median of 6.08)
GF Value™: ¥19.55 vs. price of ¥19.09 (2.4% below fair value)
Industry Position: 275.1% above the Medical Devices & Instruments median (#688 of 786)
No single metric tells the full story. See the SHSE:688277 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tinavi Medical Technologies Co Business Description
AddressJianfeng Road South Extension, Building 2, Courtyard 8, Jinyu Science and Technology Park, Zhongguancun Xisanqi, Haidian District, Beijing, CHN, 100096
Tinavi Medical Technologies Co Ltd is engaged in the Research, development, production, sales and service of orthopedic surgical navigation and positioning robots.
74GF Score
Get the complete analysis for SHSE:688277
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688277 has been successfully added to your 
